Upgrade to SI Premium - Free Trial

Dianthus Therapeutics (DNTH) PT Raised to $98 at Jefferies

March 9, 2026 3:51 PM
Jefferies analyst Maury Raycroft raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $98.00 (from $81.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change